Lentivirally Redirected CD123 Autologous T Cells in AML

Clinical trial NCT03766126 · TERMINATED

Trial details

NCT number: NCT03766126
Sponsor: University of Pennsylvania
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, in Relapse Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia, Refractory

Start date: 2018-12-06
Primary completion: 2026-03-05
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.